<?xml version="1.0"?>
<rss version="2.0">
	<channel>
		<title>News for Germany-based  companies .</title>
		<link>http://www.lifescience-online.com/</link>
		<description>News Feed Powered by Lifescience-online.com</description>
		<language>en-us</language>
		<pubDate>Wed, 07 Jan 2009 13:09:13 +0100</pubDate>
		<lastBuildDate>Wed, 07 Jan 2009 13:09:13 +0100</lastBuildDate>
		<category>News</category>		

		<image>
			<title>Lifescience-online</title>
			<url>http://rss.lifescience-online.com/images/logo.gif</url>
			<link>http://www.lifescience-online.com/</link>
			<width></width>
			<height></height>
			<description>Lifescience-online</description>
		</image>

		<item>
			<title>PAION and ERGOMED Complete Enrolment of Phase IIa Study with CNS 5161 in Opioid-Refractory Cancer Pain</title>
			<link>http://www.lifescience-online.com/PAION_and_ERGOMED_Complete_Enrolment_of_Phase_IIa_,13505.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/5/2.gif' /></div><dl><dt><b>Category</b> :</dt><dd>Scientific - Pipeline - Regulatory</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/cenes_pharmaceuticals,5334.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>CENES PHARMACEUTICALS</u></font></a><br /><a href='http://www.lifescience-online.com/ergomed_group,9552.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>ERGOMED GROUP</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/CNS-5161,1876.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>CNS-5161</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Sun, 21 Dec 2008 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>Mologen AG (MOLGF.PK): European Commission (EC) Grants EUR 3 Million to Develop DNA Vaccine for Humans</title>
			<link>http://www.lifescience-online.com/Mologen_AG__MOLGF_PK___European_Commission__EC__Gr,13480.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/6/2.gif' /></div><dl><dt><b>Category</b> :</dt><dd>Finance and Income</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/mologen,6164.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>MOLOGEN AG</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Thu, 18 Dec 2008 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>KeyNeurotek Pharmaceuticals Concludes Patient Recruitment In A Phase IIa Traumatic Brain Injury Study With KN38-7271 On Schedule</title>
			<link>http://www.lifescience-online.com/KeyNeurotek_Pharmaceuticals_Concludes_Patient_Recr,13361.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/5/0.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Central Nervous System</dd><br /><dt><b>Category</b> :</dt><dd>Scientific - Pipeline - Regulatory</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/keyneurotek,9738.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>KEYNEUROTEK AG</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/KN38-7271,1202.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>KN38-7271</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Sun, 14 Dec 2008 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>Joern Aldag Resigns as CEO of Evotec AG</title>
			<link>http://www.lifescience-online.com/Joern_Aldag_Resigns_as_CEO_of_Evotec_AG,13330.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/2/3.gif' /></div><dl><dt><b>Category</b> :</dt><dd>Management and Decision</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/evotec,1226.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>EVOTEC AG</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Wed, 10 Dec 2008 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>MorphoSys Announces Second Clinical Milestone in Therapeutic Antibody Program</title>
			<link>http://www.lifescience-online.com/MorphoSys_Announces_Second_Clinical_Milestone_in_T,13342.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/6/1.gif' /></div><dl><dt><b>Category</b> :</dt><dd>Finance and Income</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/morphosys,6172.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>MORPHOSYS AG</u></font></a><br /><a href='http://www.lifescience-online.com/centocor,7699.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>CENTOCOR INC</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Wed, 10 Dec 2008 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>Proteo Inc./Proteo Biotech AG - Minapharm/Rhein Minapharm Biogenetics SAE: Approval for a Phase II Clinical Trial with Elafin in Kidney Transplantation</title>
			<link>http://www.lifescience-online.com/Proteo_Inc__Proteo_Biotech_AG___Minapharm_Rhein_Mi,13303.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/5/3.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Immunomodulation</dd><br /><dt><b>Category</b> :</dt><dd>Scientific - Pipeline - Regulatory</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/proteo_biotech,6531.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>PROTEO BIOTECH AG</u></font></a><br /><a href='http://www.lifescience-online.com/minapharm_pharmaceuticals_sae,10175.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>Minapharm Pharmaceuticals SAE</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/ELAFIN,7010.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>ELAFIN</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Tue, 09 Dec 2008 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>GPC Biotech Opens Enrollment in Phase 1 Trial Evaluating RGB-286638 Multi-Targeted Protein Kinase Inhibitor in Patients with Advanced Solid Tumors</title>
			<link>http://www.lifescience-online.com/GPC_Biotech_Opens_Enrollment_in_Phase_1_Trial_Eval,13207.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/5/2.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Oncology</dd><br /><dt><b>Category</b> :</dt><dd>Scientific - Pipeline - Regulatory</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/gpc_biotech,1165.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>GPC BIOTECH AG</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/RGB-286638,24259.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>RGB-286638</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Tue, 09 Dec 2008 16:06:24 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>GPC Biotech Announces Presentation of New Pre-Clinical Data on RGB-286638 Multi-Targeted Kinase Inhibitor at the American Society of Hematology Annual Meeting</title>
			<link>http://www.lifescience-online.com/GPC_Biotech_Announces_Presentation_of_New_Pre_Clin,13193.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/5/2.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Oncology</dd><br /><dt><b>Category</b> :</dt><dd>Scientific - Pipeline - Regulatory</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/gpc_biotech,1165.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>GPC BIOTECH AG</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/RGB-286638,24259.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>RGB-286638</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Mon, 08 Dec 2008 10:24:09 GMT</pubDate>
			<category>News</category>
		</item>

	</channel>
</rss>